FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052804922> ?p ?o ?g. }

• W2052804922 endingPage "25" @default.
• W2052804922 startingPage "16" @default.
• W2052804922 abstract "6-Nitro-7-hydroxycoumarin (6-NO2-7-OHC) and 3,6,8-trinitro-7-hydroxycoumarin (3,6,8-NO2-7-OHC) have previously been shown to be potent and selective anti-proliferative agents in a human melanoma cell line. These agents functioned by decreasing DNA synthesis, through an inhibition of the S phase regulatory protein, cyclin A. However, the key molecular target(s) for these drugs remained undefined. Here, we attempted to elucidate the exact nature of the relationship between drug exposure and signal transduction, particularly their effects on the mitogen activated protein kinase (MAPK) cascades, and the consequent effect on cell growth, death and differentiation. Comparative studies were carried out using 7-hydroxycoumarin (7-OHC). Both nitro-derivatives were found to alter the phosphorylation status of ERK1/ERK2 and p38. However, 7-OHC exerted this effect only at higher concentrations and longer incubation times. Also, none of the three drugs had any effect on SAPK phosphorylation. Tyrosinase activity assays and morphological studies were used to show drug-induced effects on cellular differentiation. Unlike 7-OHC, both 6-NO2-7-OHC and 3,6,8-NO2-7-OHC caused a dramatic increase in tyrosinase activity in a manner similar to the cAMP elevating agent, forskolin. Also, the MEK inhibitor (PD98059) in combination with nitro-derivatives stimulated an even greater increase in tyrosinase activity when compared to either drug. In addition, the p38 inhibitor (SB203580) reduced the activity of both drugs. Morphological examination of treated cells showed nitro-derivatives caused changes consistent with altered cellular differentiation. Taken together, we have established that exposure of human malignant melanoma cells to these drugs leads to a modulation of p38 MAP kinase phosphorylation. This implies that these drugs may function by altering both melanogenesis and cellular differentiation. However, their effect on the levels of these proteins rather than their phosphorylation status remains to be determined. Therefore, additional studies are underway in order to identify the exact binding partners for these drugs." @default.
• W2052804922 created "2016-06-24" @default.
• W2052804922 creator A5037706114 @default.
• W2052804922 creator A5068446838 @default.
• W2052804922 creator A5081539782 @default.
• W2052804922 date "2005-09-01" @default.
• W2052804922 modified "2023-09-27" @default.
• W2052804922 title "Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cells" @default.
• W2052804922 cites W12457287 @default.
• W2052804922 cites W1968480589 @default.
• W2052804922 cites W1973053546 @default.
• W2052804922 cites W1973532879 @default.
• W2052804922 cites W1979972866 @default.
• W2052804922 cites W1981262353 @default.
• W2052804922 cites W1985779313 @default.
• W2052804922 cites W1989089243 @default.
• W2052804922 cites W1990305888 @default.
• W2052804922 cites W1990508640 @default.
• W2052804922 cites W1990605643 @default.
• W2052804922 cites W1990629983 @default.
• W2052804922 cites W2001099356 @default.
• W2052804922 cites W2003724801 @default.
• W2052804922 cites W2005075550 @default.
• W2052804922 cites W2010790710 @default.
• W2052804922 cites W2011469832 @default.
• W2052804922 cites W2036917320 @default.
• W2052804922 cites W2039859755 @default.
• W2052804922 cites W2044533597 @default.
• W2052804922 cites W2047745715 @default.
• W2052804922 cites W2052410183 @default.
• W2052804922 cites W2057773769 @default.
• W2052804922 cites W2061394487 @default.
• W2052804922 cites W2064480241 @default.
• W2052804922 cites W2075098591 @default.
• W2052804922 cites W2079710223 @default.
• W2052804922 cites W2086405090 @default.
• W2052804922 cites W2091273633 @default.
• W2052804922 cites W2092537202 @default.
• W2052804922 cites W2146407788 @default.
• W2052804922 cites W2151878529 @default.
• W2052804922 cites W2163188200 @default.
• W2052804922 cites W4247411266 @default.
• W2052804922 doi "https://doi.org/10.1016/j.ejps.2005.04.016" @default.
• W2052804922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15996858" @default.
• W2052804922 hasPublicationYear "2005" @default.
• W2052804922 type Work @default.
• W2052804922 sameAs 2052804922 @default.
• W2052804922 citedByCount "52" @default.
• W2052804922 countsByYear W20528049222012 @default.
• W2052804922 countsByYear W20528049222013 @default.
• W2052804922 countsByYear W20528049222014 @default.
• W2052804922 countsByYear W20528049222015 @default.
• W2052804922 countsByYear W20528049222016 @default.
• W2052804922 countsByYear W20528049222017 @default.
• W2052804922 countsByYear W20528049222018 @default.
• W2052804922 countsByYear W20528049222019 @default.
• W2052804922 countsByYear W20528049222023 @default.
• W2052804922 crossrefType "journal-article" @default.
• W2052804922 hasAuthorship W2052804922A5037706114 @default.
• W2052804922 hasAuthorship W2052804922A5068446838 @default.
• W2052804922 hasAuthorship W2052804922A5081539782 @default.
• W2052804922 hasConcept C11960822 @default.
• W2052804922 hasConcept C132149769 @default.
• W2052804922 hasConcept C181199279 @default.
• W2052804922 hasConcept C184235292 @default.
• W2052804922 hasConcept C185592680 @default.
• W2052804922 hasConcept C2777658100 @default.
• W2052804922 hasConcept C2781249067 @default.
• W2052804922 hasConcept C502942594 @default.
• W2052804922 hasConcept C51551487 @default.
• W2052804922 hasConcept C552990157 @default.
• W2052804922 hasConcept C55493867 @default.
• W2052804922 hasConcept C57074206 @default.
• W2052804922 hasConcept C62112901 @default.
• W2052804922 hasConcept C62478195 @default.
• W2052804922 hasConcept C64241487 @default.
• W2052804922 hasConcept C86803240 @default.
• W2052804922 hasConcept C87554066 @default.
• W2052804922 hasConcept C95444343 @default.
• W2052804922 hasConcept C97029542 @default.
• W2052804922 hasConcept C98274493 @default.
• W2052804922 hasConceptScore W2052804922C11960822 @default.
• W2052804922 hasConceptScore W2052804922C132149769 @default.
• W2052804922 hasConceptScore W2052804922C181199279 @default.
• W2052804922 hasConceptScore W2052804922C184235292 @default.
• W2052804922 hasConceptScore W2052804922C185592680 @default.
• W2052804922 hasConceptScore W2052804922C2777658100 @default.
• W2052804922 hasConceptScore W2052804922C2781249067 @default.
• W2052804922 hasConceptScore W2052804922C502942594 @default.
• W2052804922 hasConceptScore W2052804922C51551487 @default.
• W2052804922 hasConceptScore W2052804922C552990157 @default.
• W2052804922 hasConceptScore W2052804922C55493867 @default.
• W2052804922 hasConceptScore W2052804922C57074206 @default.
• W2052804922 hasConceptScore W2052804922C62112901 @default.
• W2052804922 hasConceptScore W2052804922C62478195 @default.
• W2052804922 hasConceptScore W2052804922C64241487 @default.
• W2052804922 hasConceptScore W2052804922C86803240 @default.
• W2052804922 hasConceptScore W2052804922C87554066 @default.

• next